Endometrial Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Endometrial Cancer
  • Endometrial Cancer Precursors
    • Birmingham, Alabama
      University of Alabama
    2022-04-07
    Apr 7, 2022
    N
    Active, not recruiting
    • Ovarian Cancer
    • +4 more
      • New York, New York
        Columbia University
      2022-04-07
      Apr 7, 2022
      N
      Recruiting
      • Cervical Cancer
      • +4 more
      • HDR Brachytherapy
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      E
      Recruiting
      • Breast Cancer
      • +3 more
      • Gilbert, Arizona
      • +77 more
      2022-04-06
      Apr 6, 2022
      L
      Available
      • Esophageal Neoplasm
      • +9 more
      • Birmingham, Alabama
      • +3 more
      2022-04-05
      Apr 5, 2022
      A
      Recruiting
      • Endometrial Cancer
      • Atezolizumab - 28 Day Cycle
      • +6 more
      • Duarte, California
      • +10 more
      2022-04-05
      Apr 5, 2022
      K
      Active, not recruiting
      • Endometrial Cancer
      • Phoenix, Arizona
      • +100 more
      2022-04-04
      Apr 4, 2022
      M
      Active, not recruiting
      • Endometrial Cancer
      • Uterine Carcinosarcoma
      • New York, New York
      • +2 more
      2022-04-04
      Apr 4, 2022
      A
      Recruiting
      • Gynecologic Cancer
      • +11 more
      • Neoantigen specific TCR-T cell drug product
      • Aldesleukin (IL-2)
      • Houston, Texas
        MD Anderson Cancer Center
      2022-04-01
      Apr 1, 2022
      L
      Not yet recruiting
      • Endometrial Cancer
      • Toronto, Canada
      • +5 more
      2022-03-22
      Mar 22, 2022
      C
      Recruiting
      • Ovarian Cancer
      • +4 more
      • Physiological intervention
      • +2 more
      • Prague, Czechia
        Gynecologic Oncology Center in Prague
      2022-03-29
      Mar 29, 2022
      A
      Recruiting
      • Ovarian Cancer
      • +12 more
      • Duarte, California
      • +40 more
      2022-03-30
      Mar 30, 2022
      I
      Completed
      • Colorectal Cancer (CRC)
      • +10 more
      • San Francisco, California
      • +16 more
      2022-03-30
      Mar 30, 2022
      E
      Completed
      • Solid Tumors
      • +11 more
      • Boston, Massachusetts
      • +8 more
      2022-03-18
      Mar 18, 2022
      M
      Completed
      • Endometrial Cancer
      • Recurrent Endometrial Cancer
      • Basking Ridge, New Jersey
      • +5 more
      2022-03-28
      Mar 28, 2022
      A
      Active, not recruiting
      • Advanced Solid Malignancy
      • +13 more
      • Los Angeles, California
      • +33 more
      2022-03-28
      Mar 28, 2022
      C
      Recruiting
      • Non-Small Cell Lung Cancer
      • +12 more
      • Tucson, Arizona
      • +26 more
      2022-03-24
      Mar 24, 2022
      A
      Recruiting
      • Breast Cancer
      • +3 more
      • Duarte, California
      • +8 more
      2022-03-23
      Mar 23, 2022
      X
      Not yet recruiting
      • Ovarian Cancer
      • +4 more
      • XmAb20717
      • (no location specified)
      2022-03-22
      Mar 22, 2022
      E
      Recruiting
      • Ovarian Cancer
      • +68 more
      • Phoenix, Arizona
      • +6 more
      2022-03-21
      Mar 21, 2022
      D
      Not yet recruiting
      • Ovarian Cancer
      • +6 more
      • Exercise
      • Attention Control
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      2022-03-21
      Mar 21, 2022